P

Inventor

LIM BING

SG13 patents
⚠️ This page may combine multiple inventors who share the name “LIM BING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BETH ISRAEL HOSPITAL

4 patents
US5705615AJan 6, 1998

Antibodies specific for HTm4

BETH ISRAEL HOSPITAL15 citations79
US5972688AOct 26, 1999

HTm4 methods of treatment and assays, agonists and antagonists

BETH ISRAEL HOSPITAL5 citations71
US5767073AJun 16, 1998

D4 gene and methods of use thereof

BETH ISRAEL HOSPITAL7 citations69
US5585478ADec 17, 1996

D4 gene and methods of use thereof

BETH ISRAEL HOSPITAL4 citations58

AGENCY SCIENCE TECH & RES

4 patents
US11872230B2Jan 16, 2024

Method of treating a methionine-dependent cancer

AGENCY SCIENCE TECH & RES0 citations55
US11376256B2Jul 5, 2022

Method of treating a methionine-dependent cancer

AGENCY SCIENCE TECH & RES1 citations55
US11072795B2Jul 27, 2021

Antisense oligonucleotides

AGENCY SCIENCE TECH & RES0 citations53
US11180733B2Nov 23, 2021

Method of generating mesenchymal stem cells and uses thereof

AGENCY SCIENCE TECH & RES0 citations40

LIM BING

2 patents
US9297813B2Mar 29, 2016

Targeting metabolic enzymes in human cancer

LIM BING1 citations44
US8889412B2Nov 18, 2014

Methods of enhancing pluripotentcy

LIM BING1 citations42

BETH ISRAEL HOSPITAL BOSTON

1 patent
US5552312ASep 3, 1996

Recombinant HTm4 gene, protein and assays

BETH ISRAEL HOSPITAL BOSTON3 citations54

(unassigned)

1 patent
US6153403ANov 28, 2000

Lysosomal-associated multispanning membrane protein, LAPTM5 and nucleic acid encoding LAPTM5

0 citations49

MILLER LANCE D

1 patent
US8663915B2Mar 4, 2014

Methods of controlling tumorigenesis and diagnosing the risk thereof

MILLER LANCE D1 citations48